Cargando…

Reciprocal crosstalk between endometrial carcinoma and mesenchymal stem cells via transforming growth factor-β/transforming growth factor receptor and C–X–C motif chemokine ligand 12/C–X–C chemokine receptor type 4 aggravates malignant phenotypes

Designated for cyclic shedding, the endometrial stroma is rich in endometrial mesenchymal stem cells (EMSCs) and may play an important role in the development of endometrial carcinoma (EC). This study characterized the crosstalk of EC cells with EMSCs and the resultant effects on malignant phenotype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Dah-Ching, Chu, Tang-Yuan, Liu, Hwan-Wun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777765/ https://www.ncbi.nlm.nih.gov/pubmed/29383153 http://dx.doi.org/10.18632/oncotarget.23212

Ejemplares similares

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
por: Wani, Nissar Ahmad, et al.
Publicado: (2014)

Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer
por: Sun, Jiping, et al.
Publicado: (2022)

Interaction between epidermal growth factor receptor and C-C motif chemokine receptor 2 in the ovulatory cascade
por: Conte, J. G., et al.
Publicado: (2023)

Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility
por: Zhou, Jing, et al.
Publicado: (2021)

Evaluation of the influence of the C-X-C motif chemokine ligand 12 / C-X-C chemokine receptor 4 axis on canine mammary gland tumor cell migration
por: KUDO, Ayano, et al.
Publicado: (2023)

Partial agonist activity of α(1)-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3
por: Gao, Xianlong, et al.
Publicado: (2018)

Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis
por: Li, Yi‐Ming, et al.
Publicado: (2019)

Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2
por: Cho, Hee Seong, et al.
Publicado: (2023)

Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease
por: Feng, Siqi, et al.
Publicado: (2015)

Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model
por: MA, TENG, et al.
Publicado: (2015)

Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer
por: ZENG, HENG, et al.
Publicado: (2014)

Bioinformatics approach reveals the key role of C-X-C motif chemokine receptor 2 in endometriosis development
por: Tan, Aili, et al.
Publicado: (2018)

Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction
por: Sun, Yutian, et al.
Publicado: (2022)

Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4–Directed Molecular Imaging and Therapy
por: Hartrampf, Philipp E., et al.
Publicado: (2023)

C-X-C receptor 7 agonist acts as a C-X-C motif chemokine ligand 12 inhibitor to ameliorate osteoclastogenesis and bone resorption
por: Nugraha, Alexander Patera, et al.
Publicado: (2022)

C‐X‐C motif chemokine receptor 4 aggravates renal fibrosis through activating JAK/STAT/GSK3β/β‐catenin pathway
por: Liu, Yahong, et al.
Publicado: (2020)

Deflection of vascular endothelial growth factor action by SS18–SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma
por: Wakamatsu, Toru, et al.
Publicado: (2014)

Loss of atypical chemokine receptor 4 facilitates C-C motif chemokine ligand 21-mediated tumor growth and invasion in nasopharyngeal carcinoma
por: Ju, Yunhe, et al.
Publicado: (2019)

New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle
por: Evans, Ann E., et al.
Publicado: (2016)

Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1（CXCL1） and C-X-C Motif Chemokine Ligand 6（CXCL6） in models of early alcoholic liver disease
por: Jiang, Yao, et al.
Publicado: (2022)

Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
por: Yumimoto, Kanae, et al.
Publicado: (2019)

α(1)‐Adrenergic Receptors Function Within Hetero‐Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C‐X‐C motif) Receptor 4 in Vascular Smooth Muscle Cells
por: Albee, Lauren J., et al.
Publicado: (2017)

MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis
por: Yan, Yali, et al.
Publicado: (2022)

Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo
por: Aguilera-Durán, Giovanny, et al.
Publicado: (2020)

The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling
por: Li, Chunyan, et al.
Publicado: (2015)

Role of Chemokine (C–X–C Motif) Ligand 10 (CXCL10) in Renal Diseases
por: Gao, Jie, et al.
Publicado: (2020)

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
por: Wu, Qianmiao, et al.
Publicado: (2022)

The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors
por: Zhang, Chao, et al.
Publicado: (2017)

Inducible Costimulator-C-X-C Motif Chemokine Receptor 3 Signaling is Involved in Chronic Obstructive Pulmonary Disease Pathogenesis
por: Li, Dan-Yang, et al.
Publicado: (2022)

Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α(1)-adrenergic receptors at the heteromeric receptor complex
por: Gao, Xianlong, et al.
Publicado: (2018)

C-X-C motif chemokine 16, modulated by microRNA-545, aggravates myocardial damage and affects the inflammatory responses in myocardial infarction
por: Liang, Fang-Qian, et al.
Publicado: (2021)

Abnormal expression of fibrosis markers, estrogen receptor α and stromal derived factor-1/chemokine (C-X-C motif) receptor-4 axis in intrauterine adhesions
por: Zhou, Qin, et al.
Publicado: (2018)

Insulin‐like growth factor binding protein‐4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C‐X‐C chemokine receptor 4
por: Su, YunYun, et al.
Publicado: (2019)

Salmonella reduces tumor metastasis by downregulation C-X-C chemokine receptor type 4
por: Lee, Tai-Huang, et al.
Publicado: (2021)

Expression of C–C motif chemokines and their receptors in bovine placentomes at spontaneous and induced parturition
por: HIRAYAMA, Hiroki, et al.
Publicado: (2019)

Clinical Significance of C-X-C Motif Chemokine Receptor 4 and Integrin αvβ6 Expression in Breast Cancer
por: Huang, Hongshan, et al.
Publicado: (2020)

Blockage of C-X-C Motif Chemokine Receptor 2 (CXCR2) Suppressed Uric Acid (UA)-Induced Cardiac Remodeling
por: Xu, Mingxi, et al.
Publicado: (2021)

C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression
por: Yang, Xiao-Yan, et al.
Publicado: (2019)

C-X-C Motif Chemokine 10 Impairs Autophagy and Autolysosome Formation in Non-alcoholic Steatohepatitis
por: Zhang, Xiang, et al.
Publicado: (2017)

Diagnostic and prognostic values of C-X-C motif chemokine ligand 3 in patients with colon cancer
por: Ruan, Guo-Tian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h9n5v1e2q0opb832rmbauksrmf